Olympus Corporation operates in the Electromedical equipment sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Olympus with three other
medical equipment manufacturers in Asia:
Fukuda Denshi Co., Ltd.
sales of 128.88 billion Japanese Yen [US$1.15 billion]
of which 39%
was Treatment Equipment),
Japan Lifeline Co., Ltd.
(42.30 billion Japanese Yen [US$376.45 million]
of which 48%
was EP/Application), and
Nihon Kohden Corporation
(174.25 billion Japanese Yen [US$1.55 billion]
of which 34%
was Biological Information Monitors).
Olympus reported sales of ¥786.50 billion (US$7.00 billion)
March of 2018.
increase of 5.1%
versus 2017, when the company's sales were ¥748.05 billion.
Despite this increase, sales are still
below the level achieved in 2016, when Olympus
reported sales of ¥804.58 billion.
The sales level in 2018 was fairly close to the level five years ago: in 2013, Olympus had sales
of ¥743.85 billion.
Sales of Science saw an increase
7.3% in 2018, from
¥93.23 billion to ¥100.02 billion.
Not all segments of Olympus experienced an increase in sales in 2018:
sales of Other fell 29.4% to ¥9.85 billion.
(However, this segment's sales were only a very small portion of the company's overall sales).
Olympus also experienced decreases in sales in
the Video (down 8.0% to ¥60.30 billion)